175 related articles for article (PubMed ID: 17308266)
1. What is the most cost-effective population-based cancer screening program for Chinese women?
Woo PP; Kim JJ; Leung GM
J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
3. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
Gyrd-Hansen D
Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening the average-risk population for colorectal cancer.
Provenzale D
Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of mammography screening for Chinese women.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
[TBL] [Abstract][Full Text] [Related]
10. The role of health insurance coverage in cancer screening utilization.
Robinson JM; Shavers V
J Health Care Poor Underserved; 2008 Aug; 19(3):842-56. PubMed ID: 18677074
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
12. Cancer screening before and after switching to a high-deductible health plan.
Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
[TBL] [Abstract][Full Text] [Related]
13. [Methods to increase participation in cancer screening programmes].
Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
[TBL] [Abstract][Full Text] [Related]
14. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
18. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
19. Using Risk Stratification to Optimize Mammography Screening in Chinese Women.
Leung K; Wu JT; Wong IO; Shu XO; Zheng W; Wen W; Khoo US; Ngan R; Kwong A; Leung GM
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377936
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
